-
RNA-seq data from 121 tumor samples with muscle invasive bladder cancer.
Study
EGAS00001004505
-
WES data from 165 tumor/germline samples with muscle invasive bladder cancer.
Study
EGAS00001004507
-
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer
Study
EGAS00001004510
-
IN UTERO ORIGIN OF MYELOFIBROSIS PRESENTING IN ADULT MONOZYGOTIC TWINS AFTER A PROLONGED DISEASE LATENCY
Study
EGAS00001005744
-
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
Study
EGAS00001004525
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
The Genomic Landscape of Prostate Cancer Brain Metastases
Study
EGAS00001004557
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
RNASeq of PDX and CDX tumours treated with ADC
Study
EGAS00001004562
-
Molecular sub-classification of hormone receptor-positive breast cancer
Study
EGAS00001004594
-
Functional screening on patient-derived organoids identifies a therapeutic bispecific antibody that triggers EGFR degradation in LGR5+ tumor cells
Study
EGAS00001004584
-
Gene expression profiles of disseminated breast cancer cells
Study
EGAS00001004597
-
Whole Exome Sequencing of High grade T1 non-muscle invasive bladder cancer
Study
EGAS00001004603